Scarica l'app Stockscreener
327.47
0.47%
1.53
Dopo l'orario di chiusura:
327.47
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$325.94
Aprire:
$325.72
Volume 24 ore:
328.49K
Relative Volume:
1.29
Capitalizzazione di mercato:
$9.17B
Reddito:
$2.58B
Utile/perdita netta:
$-778.69M
Rapporto P/E:
-55.98
EPS:
-5.85
Flusso di cassa netto:
$223.75M
1 W Prestazione:
-2.62%
1M Prestazione:
+1.17%
6M Prestazione:
+14.65%
1 anno Prestazione:
+6.21%
Intervallo 1D:
$325.72
$334.10
Intervallo di 1 settimana:
$318.27
$351.08
Portata 52W:
$262.12
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Nome
Bio Rad Laboratories Inc
Settore
Industria
Telefono
(510) 724-7000
Indirizzo
1000 ALFRED NOBEL DRIVE, HERCULES
Confronta BIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
327.47 | 9.17B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
114.23 | 198.13B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
364.60 | 138.99B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
88.95 | 131.10B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
81.03 | 103.90B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.81 | 44.12B | 6.60B | 4.16B | 490.10M | 6.93 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-03 | Downgrade | Citigroup | Buy → Neutral |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-06-16 | Iniziato | Wells Fargo | Overweight |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-01-28 | Reiterato | Citigroup | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2018-10-17 | Iniziato | Goldman | Buy |
| 2018-09-20 | Iniziato | Morgan Stanley | Equal-Weight |
| 2018-02-16 | Downgrade | CL King | Buy → Neutral |
| 2017-07-13 | Iniziato | Wells Fargo | Outperform |
| 2017-06-28 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Hold |
| 2016-10-13 | Iniziato | CL King | Buy |
| 2015-05-06 | Reiterato | Jefferies | Buy |
| 2009-12-18 | Iniziato | Maxim Group | Buy |
| 2009-11-06 | Iniziato | Jefferies & Co | Buy |
| 2009-07-17 | Iniziato | Soleil | Buy |
| 2007-09-26 | Iniziato | Banc of America Sec | Buy |
| 2007-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mostra tutto
Bio Rad Laboratories Inc Borsa (BIO) Ultime notizie
FY2024 Earnings Estimate for BIO Issued By Zacks Research - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Geode Capital Management LLC - MarketBeat
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap DownHere's Why - MarketBeat
Bio-Rad's SWOT analysis: life science firm's stock faces mixed outlook - Investing.com
Wellington Management Group LLP Boosts Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Franklin Resources Inc. - MarketBeat
Retirement Systems of Alabama Has $7.78 Million Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
DNA/RNA Sample Extraction and Isolation Market Top Companies - openPR
Metagenomics Market to See Booming Growth 2024-2031 | Bio-Rad - openPR
Life Science Products Market Overall Study Report 2024-2031 | - openPR
DNA and RNA Sample Preparation Market Future Business - openPR
Toronto Dominion Bank Decreases Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Surface Plasmon Resonance Market Detailed In New Research - openPR
Macrophage Markers Market Top Companies StudyAbcam plc, - openPR
Bio-Rad Laboratories (NYSE:BIO.B) Trading Up 2.3%Should You Buy? - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Sees Significant Decrease in Short Interest - MarketBeat
Is Bio-Rad Laboratories (NYSE:BIO) Using Too Much Debt? - Simply Wall St
Bio-Rad Receives NF Validation for iQ-Check Listeria spp. and iQ-Check Listeria monocytogenes Shortened Enrichment Protocol - Quality Assurance & Food Safety
Fmr LLC Lowers Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Barclays PLC Reduces Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Bio-Rad receives NF validation for iQ-Check Listeria spp. and iQ-Check Listeria monocytogenes shortened enrichment protocol in all food products and environmental samples - Cambridge Network
Chromatography Resin Market Set to Reach USD 5.1 Billion by 2032 | Increasing Demand for Biopharmaceuticals Drives Market Growth - GlobeNewswire Inc.
Global Hematology Market to Exhibit Growth at a CAGR of ~8% by 2030 | DelveInsight - The Malaysian Reserve
Bio-Rad's SWOT analysis: life science firm's stock faces growth hurdles - Investing.com Canada
Teachers Retirement System of The State of Kentucky Purchases 4,138 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Comparing Vericheck ddPCR and AUC for precise AAV therapeutic genome analysis - News-Medical.Net
Research Antibodies Market Growth in Future Scope 2024-2031 | - openPR
2,626 Shares in Bio-Rad Laboratories, Inc. (NYSE:BIO) Bought by Neo Ivy Capital Management - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by State Street Corp - MarketBeat
Cytokine Market Is Booming Worldwide 2024-2031 | Abbott, AB - openPR
Molecular Weight Marker Market Emerging Trends and Growth - openPR
Key Trends in the Cell Culture Media And Additives Market with - openPR
Human Proteome Microarray Market Industry Dynamics - openPR
Zacks Investment Management Acquires New Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
India Microfluidics Market Report 2024, with Profiles of AQC Chem. Lab, Bio-Rad Laboratories India, Abbott India, PerkinElmer India and Thermo Fisher Scientific India - Yahoo Finance
Viral Vector Purification Market Key Players AnalysisAgilent - openPR
Molecular Quality Controls Market Types and Applications, - openPR
Cell LysisCell Fractionation Market Size Estimation, Future - openPR
RNA Analysis Transcriptomics Market Key Players Analysis - openPR
Polymerase Chain Reaction (PCR) Market Size, Trends, Growth, - openPR
Bio-Rad Laboratories: Digital PCR Platform Expansion &3 Critical Factors Driving Our Optimism!Financial Forecasts - Smartkarma
Y Intercept Hong Kong Ltd Makes New Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Macrophage Marker Market Landscape: Trends, Drivers, - openPR
Liquid Biopsy Market Poised for Substantial Growth (2024-2031) - openPR
In Vitro Diagnostic (IVD) Reagents Market Top PlayersThermo - openPR
Bio Rad Laboratories (BIO) Stock Surges Amid Positive Financial Performance - GuruFocus.com
Bio-Rad Laboratories (NYSE:BIO) Price Target Raised to $481.00 - MarketBeat
HbA1c Testing Market Opportunities, Challenges, and Growth - openPR
Bio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Vector Purification Market is Set to Grow with a Strong CAGR 21.3% - openPR
Key Trends in the Biochemicals Market with Insights from - openPR
Bio Rad Laboratories Inc Azioni (BIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.54%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):